9783764365950 - antirheumatic therapy: actions and outcomes (progress in inflammation research) (14 resultados)
Antirheumatic Therapy : Actions and Outcomes; (Progress in Inflammation Research Series)
Richard O. Day; Daniel E. Furst; Piet L.C.M. Van Riel; Barry Bresnihan
- Tapa dura
Librería: The Book Exchange, Macclesfield, CHESH, Reino UnidoThe Book Exchange
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Muy bueno
EUR 16,09
Envío por EUR 23,18Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. Condición: Near Fine. No Jacket. 3764365951. Pictorial board hardcover, from closed pharmaceutical company library. Lending record shows this book has never been borrowed. 344 pages, index, refs, illustrated with charts, photos and diagrams. A comprehensive overview of disease-modifying antirheumatic drugs (DMARDs). T…he introductory general chapters deal with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field; the following specific chapters characterize each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. For each agent some background is given, recent developments and influence of the treatment on patients` quality of life and long-term outcomes are presented. Contents clean, tight and bright. Book.
- Tapa dura
Librería: Universitätsbuchhandlung Herta Hold GmbH, Berlin, , AlemaniaUniversitätsbuchhandlung Herta Hold GmbH
Contactar con el vendedorVendedor de 4 estrellasCondición: Usado
EUR 12,00
Envío por EUR 30,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 2 disponibles
XII, 343 p. Hardcover Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Gestempelt. Progress in Inflammation Research. Sprache: Englisch.
Antirheumatic Therapy: Actions and Outcomes (Progress in Inflammation Research)
Day, Richard O. [Editor]; Furst, Daniel E. [Editor]; Riel, Piet L.C.M. van [Editor]; Bresnihan, Barry [Editor];
- Tapa dura
Librería: Lexington Books Inc, Idaho Falls, ID, Estados Unidos de AmericaLexington Books Inc
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Aceptable
EUR 50,17
Envío por EUR 4,96Se envía dentro de Estados Unidos de AmericaCantidad disponible: 1 disponibles
Hardcover. Condición: Good. Good+; Contents are tight and clean; Ex-Library; Hard Cover; Birkhauser; 2005; 0.
Antirheumatic Therapy : Actions And Outcomes
Day, Richard O. (EDT); Furst, Daniel E. (EDT); Riel, Piet L. C. M. Van (EDT); Bresnihan, Barry (EDT)
- Tapa dura
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de AmericaGreatBookPrices
Contactar con el vendedorVendedor de 5 estrellasCondición: Usado - Como Nuevo
EUR 186,68
Envío por EUR 2,28Se envía dentro de Estados Unidos de AmericaCantidad disponible: 15 disponibles
Condición: As New. Unread book in perfect condition.
- Tapa dura
Librería: Ria Christie Collections, Uxbridge, Reino UnidoRia Christie Collections
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 176,79
Envío por EUR 13,89Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Condición: New. In.
Antirheumatic Therapy : Actions And Outcomes
Day, Richard O. (EDT); Furst, Daniel E. (EDT); Riel, Piet L. C. M. Van (EDT); Bresnihan, Barry (EDT)
- Tapa dura
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de AmericaGreatBookPrices
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 191,07
Envío por EUR 2,28Se envía dentro de Estados Unidos de AmericaCantidad disponible: 15 disponibles
Condición: New.
Antirheumatic Therapy
. Ed(s): Day, Richard O.; Furst, Daniel E.; Van Riel, Piet L.; Bresnihan, Barry
- Tapa dura
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandaKennys Bookshop and Art Galleries Ltd.
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 198,28
Envío por EUR 10,50Se envía de Irlanda a Estados Unidos de AmericaCantidad disponible: 15 disponibles
Condición: New. Offering an overview of disease-modifying antirheumatic drugs (DMARDs), this book deals with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field. It also characterizes each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicit…y, and monitoring. Editor(s): Day, Richard O.; Furst, Daniel E.; Van Riel, Piet L.; Bresnihan, Barry. Series: Progress in Inflammation Research. Num Pages: 356 pages, biography. BIC Classification: MJM; MMG. Category: (P) Professional & Vocational; (U) Tertiary Education (US: College). Dimension: 240 x 168 x 21. Weight in Grams: 782. . 2004. Hardback. . . . .
- Tapa dura
Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 160,49
Envío por EUR 63,94Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symp…tomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy.
- Tapa dura
Librería: Revaluation Books, Exeter, , Reino UnidoRevaluation Books
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 239,34
Envío por EUR 14,49Se envía de Reino Unido a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Hardcover. Condición: Brand New. 1st edition. 343 pages. German language. 9.25x6.50x1.00 inches. In Stock.
Antirheumatic Therapy
. Ed(s): Day, Richard O.; Furst, Daniel E.; Van Riel, Piet L.; Bresnihan, Barry
- Tapa dura
Librería: Kennys Bookstore, Olney, MD, Estados Unidos de AmericaKennys Bookstore
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 247,68
Envío por EUR 9,05Se envía dentro de Estados Unidos de AmericaCantidad disponible: 15 disponibles
Condición: New. Offering an overview of disease-modifying antirheumatic drugs (DMARDs), this book deals with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field. It also characterizes each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicit…y, and monitoring. Editor(s): Day, Richard O.; Furst, Daniel E.; Van Riel, Piet L.; Bresnihan, Barry. Series: Progress in Inflammation Research. Num Pages: 356 pages, biography. BIC Classification: MJM; MMG. Category: (P) Professional & Vocational; (U) Tertiary Education (US: College). Dimension: 240 x 168 x 21. Weight in Grams: 782. . 2004. Hardback. . . . . Books ship from the US and Ireland.
Más imágenes- Tapa dura
- Impresión bajo demanda
Librería: preigu, Osnabrück, Alemaniapreigu
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 141,20
Envío por EUR 70,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 5 disponibles
Buch. Condición: Neu. Antirheumatic Therapy: Actions and Outcomes | Richard O. Day (u. a.) | Buch | xiii | Englisch | 2004 | Springer Basel | EAN 9783764365950 | Verantwortliche Person für die EU: Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com…| Anbieter: preigu Print on Demand.
- Tapa dura
- Impresión bajo demanda
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemaniabuchversandmimpf2000
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 160,49
Envío por EUR 60,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 1 disponibles
Buch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on shor…t term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy.Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 364 pp. Englisch.
Editorial: Birkhäuser Basel 2004
- Tapa dura
- Impresión bajo demanda
Librería: moluna, Greven, , Alemaniamoluna
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 136,16
Envío por EUR 48,99Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: Más de 20 disponibles
Gebunden. Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Comprehensive and well structured according to classes of agentsIncludes an outlook on future molecular targetsInternational authorshipOur goal for this book is to examine the contemporary therapy of rheumat…oid arthritis (RA) from the inc.
Editorial: Springer, Basel, Birkhäuser Basel Dez 2004 2004
- Impresión bajo demanda
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, , AlemaniaBuchWeltWeit Ludwig Meier e.K.
Contactar con el vendedorVendedor de 5 estrellasCondición: Nuevo
EUR 160,49
Envío por EUR 23,00Se envía de Alemania a Estados Unidos de AmericaCantidad disponible: 2 disponibles
Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on…short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy. 343 pp. Englisch.
